The rare disease specialty pharmacy market in the U.S. is booming, and competition between independent and national pharmacies is more intense than ever. The latest guide, "The 2025 State of Competition in the US Rare Disease Specialty Pharmacy Market," reveals how independent pharmacies leverage deep disease expertise and personalized patient care to stand out, while national pharmacies capitalize on extensive networks, robust infrastructure, and stronger payer relationships. Technological advances, payer strategies, and evolving patient support programs significantly shape this competition.
As specialty medications continue driving pharmaceutical spending, both independent and national players must adapt by focusing on value-driven care, agile service models, and strategic partnerships.
This guide is essential for specialty pharmacy professionals aiming to understand the market dynamics, overcome critical challenges, and identify winning strategies to successfully navigate this rapidly evolving sector.
Read the full guide on our website.
Did you know we also publish 20+ rare disease specific newsletters?
Our fast content and resource generation engine empowers patients with timely news, reports and community updates, while helping partners build trust and expand their influence.
